Illumina dominates the DNA sequencing market with approximately 80% market share. Its sequencing platforms have driven the cost of genome sequencing down by orders of magnitude, enabling the genomics revolution in research and clinical diagnostics.
R&D SPEND
$1.1B
INDUSTRY
Biotech
580
ACADEMIC COLLABORATIONS
4200
PATENTS
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED